Evommune, Inc.

NYSE:EVMN

Biotechnology

Healthcare
$6.88 -0.82%

-$0.17 today

Market cap
$284.49M
Beta
0.10
P/E (TTM)
-9.1
EPS (TTM)
-$2.26
52W Low $13.89High $33.20

Volume 0.60M

Average 0.38M

Balance Sheet

Inspect the capital base behind the business.

Assets

$224.95M

FY 2025 · Annual

+195.8% YoY

Liabilities

$19.38M

FY 2025 · Annual

-91.2% YoY

Equity

$205.57M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents29.02M16.25M44.06M
Short-term Investments50.06M55.79M105.14M
Net Receivables000
Inventory000
Other Current Assets948K1.95M4.28M
Total Current Assets80.03M73.99M153.48M
Property, Plant & Equipment (Net)1.97M1.8M2.46M
Goodwill000
Intangible Assets000
Long-term Investments208K208K68.9M
Tax Assets000
Other Non-current Assets44K61K101K
Total Non-current Assets2.22M2.07M71.47M
Total Assets82.25M76.06M224.95M
Account Payables1.76M8.26M7.76M
Short-term Debt769K1.02M589K
Tax Payables000
Deferred Revenue03M0
Other Current Liabilities1.89M12.07M4.63M
Total Current Liabilities6.86M27.98M17.91M
Long-term Debt149.37M191.78M0
Deferred Tax Liabilities000
Deferred Revenue (Non-current)3M00
Other Non-current Liabilities245K16K0
Total Non-current Liabilities153.11M192.31M1.47M
Total Liabilities159.96M220.29M19.38M
Common Stock1K1K3K
Retained Earnings(83.91M)(152.22M)(221.09M)
Accumulated OCI000
Other Stockholders Equity000
Minority Interest000
Total Equity(77.71M)(144.24M)205.57M
Total Debt150.63M193.31M2.06M
Net Debt121.61M177.06M(42M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$48.3M
Short-term Investments$163.1M
Other Current$4.4M
Total Current Assets$215.9M
PP&E (Net)$9.6M
Goodwill$818.1K
Intangible Assets$1.4M
Long-term Investments$97.0M
Other Non-current-$2.1M
Total Non-current Assets$106.6M
Total Assets$322.5M

Analysis

Selected assets total $322.5M for Latest. The largest visible component is Short-term Investments at $163.1M, about 50.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
424B3424B3 filingNov 12, 2026
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
SC 13D/ASC 13D/A filingNov 10, 2026
8-KCurrent reportNov 5, 2026

How much cash does EVMN have?

Evommune, Inc. (EVMN) reported $44.06M in cash and equivalents in fiscal 2025.

How much debt does EVMN carry?

Evommune, Inc. (EVMN) reported $2.06M of total debt, with net debt of -$42.00M.